Novartis Pharmaceuticals Corporation offers several programs that can help adult patients with newly diagnosed FLT3+ acute myeloid leukemia (AML) who are prescribed RYDAPT ® (midostaurin) capsules access treatment, as well as help eligible patients with out-of-pocket co-pay costs. Novartis Oncology Universal Co-pay Program
Full Answer
What is midostaurin used to treat?
INDICATIONS for RYDAPT® (midostaurin) capsules. RYDAPT is an oral prescription medicine used in combination with certain chemotherapy medicines to treat adults with newly diagnosed acute myeloid leukemia (AML) who have a defect in a gene called FLT3. Your doctor will perform a test to make sure RYDAPT is right for you.
What is the success rate of midostaurin therapy for mast cell leukemia?
With 6 cycles of midostaurin, the rates of confirmed complete remission (CR) plus incomplete remission (ICR) by modified Valent criteria were 38% for ASM and 16% for SM-AHN. One patient (5%) with mast cell leukemia achieved a CR.
What is the recommended dose of midostaurin for treatment of AML?
The recommended dose of midostaurin in AML is 50 mg twice daily with food on days 8 to 21 of each cycle of induction and consolidation chemotherapy followed by 50 mg with food as a single agent for up to 12 months. The recommended dose for the treatment of adults with aggressive systemic mastocytosis (SM),...
What is a patient assistance program?
Patient Assistance Programs for Rydapt Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program. Provider: HealthWell Foundation Copay Program
What is Novartis Patient Assistance Program?
The Novartis Patient Assistance Foundation, Inc. (NPAF) is committed to providing access to Novartis medications for those most in need. If you are experiencing financial hardship and have limited or no prescription coverage, then you may be eligible to receive Novartis medications for free.
Who manufactures Rydapt?
Novartis Pharmaceuticals Corporation offers several programs that can help adult patients with newly diagnosed FLT3+ acute myeloid leukemia (AML) who are prescribed RYDAPT® (midostaurin) capsules access treatment, as well as help eligible patients with out-of-pocket co-pay costs.
Is Midostaurin a chemo drug?
Midostaurin is a type of targeted cancer drug and daunorubicin and cytarabine are chemotherapy drugs. Midostaurin is pronounced MY-doh-STAW-rin. You pronounce daunorubicin as DAW-noh-ROO-bih-sin and cytarabine as sye-TARE-a-been. This combination of cancer drugs is a treatment for acute myeloid leukaemia (AML).
Why is Midostaurin prescribed?
Midostaurin is used in combination with standard cytarabine and daunorubicin induction and cytarabine consolidation chemotherapy to treat newly diagnosed acute myeloid leukemia (AML) in patients who are FLT3 mutation-positive.
What is midostaurin used for?
Food and Drug Administration approved midostaurin (RYDAPT, Novartis Pharmaceuticals Corp.) for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) who are FLT3 mutation-positive (FLT3+), as detected by an FDA-approved test, in combination with standard cytarabine ...
How long does midostaurin stay in your system?
The recommended dose of midostaurin in AML is 50 mg twice daily with food on days 8 to 21 of each cycle of induction and consolidation chemotherapy followed by 50 mg with food as a single agent for up to 12 months.
Is midostaurin approved for mastocytosis?
FDA also approved midostaurin for the treatment of adults with aggressive systemic mastocytosis (SM), SM with associated hematological neoplasm, or mast cell leukemia. Approval was based on response rate and duration in a single-arm, open-label study of midostaurin 100 mg orally twice daily.
How to contact Novartis oncology?
For full Terms and Conditions, visit Copay.NovartisOncology.com or call 1-877-577-7756. To find out if you are eligible for the Universal Co-pay Program, call 1-877-577-7756 or visit Copay.NovartisOncology.com. See if you're eligible.
What is a single point of contact for Novartis?
One single point of contact to help guide you through getting access to the Novartis medicine (s) prescribed by your doctor
What is rydapt used for?
RYDAPT is an oral prescription medicine used in combination with certain chemotherapy medicines to treat adults with newly diagnosed acute myeloid leukemia (AML) who have a defect in a gene called FLT3. Your doctor will perform a test to make sure RYDAPT is right for you. RYDAPT shoul ... See More.
What is PANO on Novartis?
Our Patient Assistance Now Oncology (PANO) program was created to assist you with accessing your Novartis medicine (s)—from insurance verification to financial assistance—all through a knowledgeable and supportive call center.
Does Novartis have oncology?
Novartis Oncology is committed to helping you get the Novartis medicine (s) you need. Access to medicine (s) can sometimes be difficult or confusing. PANO offers resources and support designed specifically to help make that process easier.*
Does Novartis offer AML?
Novartis Pharmaceuticals Corporation offers several programs that can help adult patients with newly diagnosed FLT3+ acute myeloid leukemia (AML) who are prescribed RYDAPT ® (midostaurin) capsules access treatment, as well as help eligible patients with out-of-pocket co-pay costs.
Is midostaurin good for cancer?
Medicines used to treat cancer are very strong and can have many side effects. Before receiving midostaurin, make sure you understand all the risks and benefits. It is important for you to work closely with your doctor during your treatment.
Can you change midostaurin?
The dose of midostaurin will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of midostaurin. If your dose is different, do not change it unless your doctor tells you to do so.
Patient Support
During advanced SM* treatment with RYDAPT, Care Coordinators are there to support your patients:
RYDAPT NOW Access Program
If you prescribe RYDAPT for aggressive systemic mastocytosis (ASM), systemic mastocytosis with an associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL), your patients may be eligible to receive a free 28-day supply of RYDAPT shipped directly to their home or another convenient location.
Rydapt Prices
The cost for Rydapt oral capsule 25 mg is around $10,431 for a supply of 56, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Rydapt Coupons and Rebates
Rydapt offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Patient Assistance Programs for Rydapt
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
What is rydapt used for?
RYDAPT is an oral prescription medicine used in combination with certain chemotherapy medicines to treat adults with newly diagnosed acute myeloid leukemia (AML) who have a defect in a gene called FLT3.
Can you use rydapt alone?
RYDAPT should not be used alone to induce remission in people with AML. RYDAPT is not safe when given to children in combination with chemotherapy. It is not known if RYDAPT is effective in children. Learn More.
Is rydapt safe for mast cell leukemia?
RYDAPT is an oral prescription medicine used to treat adults with aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL). RYDAPT is not safe when given to children in combination with chemotherapy. It is not known if RYDAPT is effective in children.
How long does midostaurin stay in your system?
Since midostaurin remains in your body for several days after it is taken , some of the drug may be present in urine, stool, sweat, or vomit. Once you have started to take midostaurin, it is important to follow the instructions below every day for as long as your treatment lasts. This will keep yourself, loved ones, and the environment as safe as possible.
Can midostaurin cause breathing problems?
Midostaurin can cause lung and breathing problems. Tell your healthcare provider right away if you have new or worsening cough, shortness of breath, chest pain, or difficulty breathing or wheezing.
Can you get pregnant while taking midostaurin?
Women should not become pregnant and men should not get a partner pregnant while taking midostaurin. Men and women of childbearing age and potential should use effective contraception during therapy and for a minimum of four months after the last dose of midostaurin.
